1 / 8

Sickle Cell Anemia Therapeutics Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024

A drastic reduction in the total red blood cells or RBC count or hemoglobin is known as anemia. It can be defined as the inability to carry optimum amount of oxygen by the blood. Sickle-cell diseases (SCD) are types of blood disorders which are usually inherited genetically. One of the common types of SCDs is the sickle-cell anemia or SCA. It essentially gives rise to an irregularity in hemoglobin, the protein that carries oxygen in the blood. Hemoglobin is found typically in the red blood cells of the body. As a result a sickle-like shaped cell is formed under certain conditions. Tribulations in sickle cell disease usually start to take shape at a very early age (within the first year of birth). This might lead to various health problems including pain attacks also known as the sickle-cell crisis, swelling in the limbs, microbial infections, and in certain cases, stroke. Chronic pain may develop with age. Sickle-cell diseases arise when an individual inherits abnormal copies of hemoglobin gene from each parent.

RupeshD
Download Presentation

Sickle Cell Anemia Therapeutics Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sickle Cell Anemia Therapeutics Market Global Market Analysis, Insights, Trends, and Opportunity Inference, 2014-2024 © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION A drastic reduction in the total red blood cells or RBC count or hemoglobin is known as anemia. It can be defined as the inability to carry optimum amount of oxygen by the blood. Sickle-cell diseases (SCD) are types of blood disorders which are usually inherited genetically. One of the common types of SCDs is the sickle-cell anemia or SCA. It essentially gives rise to an irregularity in hemoglobin, the protein that carries oxygen in the blood. Hemoglobin is found typically in the red blood cells of the body. As a result a sickle-like shaped cell is formed under certain conditions. Tribulations in sickle cell disease usually start to take shape at a very early age (within the first year of birth). This might lead to various health problems including pain attacks also known as the sickle-cell crisis, swelling in the limbs, microbial infections, and in certain cases, stroke. Chronic pain may develop with age. Sickle-cell diseases arise when an individual inherits abnormal copies of hemoglobin gene from each parent. According to Center for Disease Control and Prevention, as of 2016, around 100,000 people in the U.S. are affected by sickle cell diseases or SCDs. Sickle cell diseases are very common among black or African Americans. Around 1 in 13 babies belonging to the race are born with sickle cell diseases. Growing prevalence of the disease will give rise to an increased demand for sickle cell disease prevention and cure, thereby augmenting the growth of the overall sickle cell anemia therapeutics market. Sickle Cell Anemia Therapeutics Market: Overview

  3. Request report sample for more professional and technical insights: https://www.coherentmarketinsights.com/insight/request-sample/161 REPORT DESCRIPTION Sickle Cell Anemia Therapeutics Market Segment: • On the basis of type of medication, the global market is classified into: • Antibiotics • Pain-relieving medications • Hydroxyurea • Others • On the basis of end user, the global market is classified into: • Government • Hospitals • Private Clinics • Others

  4. REPORT DESCRIPTION • Major players involved in the sickle cell anemia therapeutics market include: • Bristol-Myers Squibb • GlycoMimetics • Pfizer • AntheraPharmaceuticals Inc. • GlycoMimetics, Inc. • Eli Lilly • Mast Therapeutics Sickle Cell Anemia Therapeutics Market: Key Players Ask For TOC: https://www.coherentmarketinsights.com/ongoing-insight/toc/161

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES

  6. ABOUT CMI SECTOR COVERAGE OUR CLIENTS BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES • Global Leading Equipment and System Manufacturers • Component Providers and System Integrators • Distributors, Retailors and Value Added Resellers • Healthcare IT Solutions Developers • Marketing Consultancies and the Advertising Industry • Private and Government organization • Outsourcing Companies • Universities and Business Schools.

  7. ABOUT US KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact:Mr. Shah(Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

More Related